110406-69-4 Usage
Description
1(2H)-Phthalazinone, 2-(1-(cyclopropylmethyl)-4-piperidinyl)-4-((4-fluorophenyl)methyl)-, monohydrochloride is a monohydrochloride salt compound with a complex molecular structure that features a piperidine ring, a cyclopropylmethyl group, and a 4-fluorophenylmethyl group. These structural elements contribute to its potential biological activity and pharmacological properties. As a monohydrochloride salt, it exhibits improved water solubility and stability compared to the free base form, making it a promising candidate for the development of pharmaceutical drugs to address a variety of medical conditions.
Uses
Used in Pharmaceutical Development:
1(2H)-Phthalazinone, 2-(1-(cyclopropylmethyl)-4-piperidinyl)-4-((4-fluorophenyl)methyl)-, monohydrochloride is used as a key compound in the development of new pharmaceutical drugs for various medical conditions. Its unique molecular structure and pharmacological properties make it a valuable asset in the search for novel treatments.
Used in Research and Development:
In the field of medicinal chemistry, this compound is used as a research tool to study its pharmacological properties and potential applications in treating different health issues. Its structural features allow scientists to explore its interactions with biological targets and evaluate its efficacy and safety in preclinical studies.
Used in Drug Synthesis:
1(2H)-Phthalazinone, 2-(1-(cyclopropylmethyl)-4-piperidinyl)-4-((4-flu orophenyl)methyl)-, monohydrochloride can also be utilized as an intermediate in the synthesis of more complex drug molecules. Its functional groups and structural elements can be further modified or combined with other molecules to create new drugs with improved properties or targeted effects.
Used in Drug Delivery Systems:
Similar to other pharmaceutical compounds, 1(2H)-Phthalazinone, 2-(1-(cyclopropylmethyl)-4-piperidinyl)-4-((4-fluorophenyl)methyl)-, monohydrochloride can be incorporated into drug delivery systems to enhance its bioavailability, targeting, and overall therapeutic efficacy. These systems can include nanoparticles, liposomes, or other advanced drug carriers designed to improve the compound's performance in vivo.
Check Digit Verification of cas no
The CAS Registry Mumber 110406-69-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,4,0 and 6 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 110406-69:
(8*1)+(7*1)+(6*0)+(5*4)+(4*0)+(3*6)+(2*6)+(1*9)=74
74 % 10 = 4
So 110406-69-4 is a valid CAS Registry Number.
InChI:InChI=1/C24H26FN3O.ClH/c25-19-9-7-17(8-10-19)15-23-21-3-1-2-4-22(21)24(29)28(26-23)20-11-13-27(14-12-20)16-18-5-6-18;/h1-4,7-10,18,20H,5-6,11-16H2;1H
